“…Despite several decades devoted to SEDDS development for various routes of administration, namely: oral, rectal, vaginal, ocular and nasal; the dermal route has remained relatively untouched [ 17 , 18 , 19 , 20 , 21 , 22 , 23 ]. The formidable barrier provided by the outermost skin layer can possibly be conquered by SEDDSs as these isotropic, thermodynamically stable mixtures, comprising oil, surface active agents and water, have the potential capacity to facilitate entry of drugs into underlying skin layers [ 24 , 25 ]. Modification of stratum corneum (SC) lipid arrangement can be achieved by natural oils included in topical SEDDSs [ 26 , 27 , 28 , 29 ].…”